Novo Nordisk A/S (NVO)
42.68
+2.50
(+6.21%)
USD |
NYSE |
Nov 04, 14:29
Novo Nordisk Total Return Price : 42.68 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 40.19 |
| November 02, 2026 | 40.45 |
| October 30, 2026 | 40.00 |
| October 29, 2026 | 39.14 |
| October 28, 2026 | 38.29 |
| October 27, 2026 | 38.67 |
| October 26, 2026 | 39.13 |
| October 23, 2026 | 39.05 |
| October 22, 2026 | 39.43 |
| October 21, 2026 | 39.06 |
| October 20, 2026 | 39.35 |
| October 19, 2026 | 38.42 |
| October 16, 2026 | 38.83 |
| October 15, 2026 | 39.22 |
| October 14, 2026 | 38.12 |
| October 13, 2026 | 38.06 |
| October 12, 2026 | 38.58 |
| October 09, 2026 | 38.64 |
| October 08, 2026 | 38.18 |
| October 07, 2026 | 38.26 |
| October 06, 2026 | 37.53 |
| October 05, 2026 | 37.54 |
| October 02, 2026 | 37.32 |
| October 01, 2026 | 37.40 |
| September 30, 2026 | 37.91 |
| Date | Value |
|---|---|
| September 29, 2026 | 38.31 |
| September 28, 2026 | 38.71 |
| September 25, 2026 | 38.80 |
| September 24, 2026 | 38.62 |
| September 23, 2026 | 38.17 |
| September 22, 2026 | 39.40 |
| September 21, 2026 | 39.80 |
| September 18, 2026 | 43.24 |
| September 17, 2026 | 43.19 |
| September 16, 2026 | 41.71 |
| September 15, 2026 | 42.53 |
| September 14, 2026 | 43.45 |
| September 11, 2026 | 43.07 |
| September 10, 2026 | 44.01 |
| September 09, 2026 | 44.56 |
| September 08, 2026 | 45.16 |
| September 04, 2026 | 46.60 |
| September 03, 2026 | 47.51 |
| September 02, 2026 | 46.77 |
| September 01, 2026 | 45.12 |
| August 31, 2026 | 45.33 |
| August 28, 2026 | 45.61 |
| August 27, 2026 | 46.26 |
| August 26, 2026 | 47.19 |
| August 25, 2026 | 48.66 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| AstraZeneca PLC | 189.02 |
| GSK Plc | 51.14 |
| Johnson & Johnson | 275.38 |
| Eli Lilly & Co. | 1421.98 |
| Merck & Co., Inc. | 148.37 |